← Browse by Condition
Medical Condition
insulin resistance
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 1, Phase 3
ClinicalMetric tracks all active clinical trials for insulin resistance sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — insulin resistance Clinical Trials
How many clinical trials are currently recruiting for insulin resistance?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for insulin resistance, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for insulin resistance?
insulin resistance research spans Phase 1 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a insulin resistance clinical trial?
Eligibility criteria for insulin resistance trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06606327 Phase 1
Recruiting
Diazoxide Suppression Test P&F Study
Enrollment
10 pts
Location
United States
Sponsor
Columbia University
NCT06847373
Recruiting
Efficacy and Safety of Vitamin D Supplementation in Pediatric Patients with Obesity
Enrollment
40 pts
Location
Mexico
Sponsor
Coordinación de Investigación ...
NCT02646475 Phase 1
Recruiting
Metabolic Effects of Angiotensin-(1-7)
Enrollment
26 pts
Location
United States
Sponsor
Vanderbilt University
NCT02947503 Phase 3
Recruiting
Pregnancy Outcomes: Effects of Metformin Study (POEM Study)
Enrollment
500 pts
Location
Netherlands
Sponsor
Bethesda Diabetes Research Cen...
NCT06912321
Recruiting
Characteristics of Papez Loop Neural Network in T2DM （Type 2 Diabetes Mellitus）
Enrollment
400 pts
Location
China
Sponsor
Nanjing First Hospital, Nanjin...
NCT06633380
Recruiting
Alternative Physical Activity Strategies for Breast Cancer Survivors
Enrollment
24 pts
Location
Canada
Sponsor
University of Toronto
NCT07483723
Recruiting
Glucose Profiles in Women With Polycystic Ovary Syndrome
Enrollment
80 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
NCT05165706
Recruiting
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
Enrollment
110 pts
Location
United States
Sponsor
Stanford University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology